Annual report [Section 13 and 15(d), not S-K Item 405]

Statements of Operations

v3.26.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenue
Operating expenses    
Research and development 17,220,401 15,480,217 [1]
General and administrative 2,227,517 2,157,010 [1]
Total operating expenses 19,447,918 17,637,227
Loss from operations (19,447,918) (17,637,227)
Interest income 89,700 223,008
Net loss $ (19,358,218) $ (17,414,219)
Per share information:    
Net loss per common share, basic $ (1.43) $ (1.34)
Net loss per common share, diluted $ (1.43) $ (1.34)
Weighted average common shares outstanding, basic 13,534,994 13,014,585
Weighted average common shares outstanding, diluted 13,534,994 13,014,585
[1] Includes reclassification of cash compensation and options expense between research and development and general and administration in 2024, which does not contribute to the change in total operating expenses for any period.